AMP v USPTO: A ruling based on misunderstanding
This article was originally published in RAJ Devices
Executive Summary
Hans Sauer argues that a blanket exclusion of gene-derived DNA molecules from patent eligibility would be counterproductive for biotech innovation.
You may also be interested in...
AMP v USPTO: A ruling based on misunderstanding
Hans Sauer argues that a blanket exclusion of gene-derived DNA molecules from patent eligibility would be counterproductive for biotech innovation.